The FDA released a new guidance titled “Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act (DSCSA) During the COVID-19 Public Health Emergency” on April 30, 2020.
Greg Cathcart, CEO of Excellis Health Solutions, is proud to moderate the panel “Are You Ready for Serialization 2017 Mandate of DSCSA?” on April 26 at the 1st Bio Supply Management Alliance (BSMA) USA Supply Chain Management Forum in Boston, MA.
The premier supply chain management conference for the biotech/pharma industry, the conference annually attracts the international “who’s who” from all branches of biotech & pharma for one solid day of high caliber networking. BSMA’s world-class sessions, workshops, panels and active exhibition make this event an unrivaled forum for companies across the biotech value chain to meet. Attend and experience how you can have more partnering meetings in just one day.
This interactive panel will cover how to prepare for the November 2017 deadline for DSCSA serialization and will address the following topics: